-
The Swiss Institute for Vaccine Research, a new initiative aligned with the scientific strategic plan of the Enterprise is launched December 5, 2007 in Lausanne, Switzerland.
-
A summary report from the Enterprise workshop titled “Antibody-Based HIV-1 Vaccine: Recent Developments and Future Directions,” is published in the December 2007 edition of PLoS Medicine.
-
Update on the STEP and Phambili studies of a Merck vaccine candidate
-
Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat.
-
Merck and the HIV Vaccine Trials Network (HVTN) announce discontinuation of vaccinations and enrollment for the STEP study after an interim analysis showed the vaccine was not effective.
-
The AIDS Vaccine 2007 conference takes place August 20-23 in Seattle, Washington
-
The AIDS Vaccine Advocacy Coalition (AVAC) releases its 2007 report, entitled “Resetting the Clock”
-
A study conducted by the US NIH's Center for HIV/AIDS Vaccine Immunology (CHAVI) has yielded a new understanding of why some people can suppress virus levels following HIV infection.
-
Canada's Government and the Bill & Melinda Gates Foundation have committed major new funding to support the Canadian HIV Vaccine Initiative.
-
The European and Developing Countries Clinical Trials Partnership (EDCTP) and the Bill & Melinda Gates Foundation launch a 20 M Euro call to develop HIV vaccine trial capacity in Africa.